Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

NCT00053976 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease

Interventions

BIOLOGICAL: Daclizumab
DRUG: methylprednisolone
DRUG: Placebo

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]